For a number of years, there has been speculation about the potential benefit of Parkinson's disease by treatment with Ginkgo biloba. In this case report, my grandfather, who had a known history of Parkinson's, had dramatic improvement after supplementation with ginkgo and a multivitamin-multimineral supplement. Human studies are needed for confirmation.
WuWR, ZhuXZ. Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice.Life Sci.1999; 65(2): 157–64.
10.
FowlerJS, WangGJ, VolkowNDEvidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain.Life Sci.2000; 66(9): PL141-6.
11.
FehskeCJ, LeunerK, MüllerWE. Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment.Pharmacol Res.2009; 60(1): 68–73.
12.
SmithPF, MaclennanK, DarlingtonCL. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).J Ethnopharmacol.1996; 50(3): 131–9.
13.
CoimbraCG, JunqueiraVB. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients.Braz J Med Biol Res.2003; 36(10): 1409–17.
14.
BirkmayerJG, VreckoC, VolcD, BirkmayerW. Nicotinamide adenine dinucleotide (NADH)—a new therapeutic approach to Parkinson's disease. Comparison of oral and parenteral application.Acta Neurol Scand Suppl.1993; 146: 32–5.
15.
FahnS. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.Ann Neurol.1992; 32 Suppl: S128–32.
16.
ZhangSM, HernánMA, ChenH, SpiegelmanD, WillettWC, AscherioA. Intakes of vitamins E and C, carotenoids, vitamin supplements, and Parkinson's disease risk.Neurology.2002; 59(8): 1161–9.
